Loading…

Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples

Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step....

Full description

Saved in:
Bibliographic Details
Published in:Mycoses 2021-06, Vol.64 (6), p.612-615
Main Authors: Mulet Bayona, Juan V., Salvador García, Carme, Tormo Palop, Nuria, Gimeno Cardona, Concepción
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03
cites cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03
container_end_page 615
container_issue 6
container_start_page 612
container_title Mycoses
container_volume 64
creator Mulet Bayona, Juan V.
Salvador García, Carme
Tormo Palop, Nuria
Gimeno Cardona, Concepción
description Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step. Objectives The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies. Methods Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland). Results The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR. Conclusions Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.
doi_str_mv 10.1111/myc.13250
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2486145885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486145885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</originalsourceid><addsrcrecordid>eNp1kctq3TAQhkVpaU6TLPICQdBNsnCii2XLy2JyKaS0lCSQlZDlEShY1qlkN5xdoC_QZ-yTVKc-6aJQbQbEN98M8yN0RMkZze_cb8wZ5UyQV2hFS94URJD6NVqRhvOiLkm9h96l9EgIrRtWvUV7nAvW8Eau0I97PbheTy6MWI89dn49gIdxWr6CxRqb4D1E4_SAI-jh1_PPyXnAX9qvWKekN9iGiHsXwUy4hymXXWubjVmO9RxdwjYGj9Mcv4MbBj0awElvp6UD9MbqIcHhru6ju8uL2_a6uPl89bH9cFMYLjgpmC07LhrT9bKSgpHOagnQNZaCphXtoKsNl4ySqjY90VyAZKIUwGzV1HVP-D46WbzrGL7NkCblXTKwXQbCnBQrZUVLIaXI6Pt_0McwxzFvp5hgJck3pSxTpwtlYkgpglXr6LyOG0WJ2iajcjLqTzKZPd4Z585D_5d8iSID5wvw5AbY_N-kPj20i_I3yx2Zww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524040712</pqid></control><display><type>article</type><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</creator><creatorcontrib>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</creatorcontrib><description>Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step. Objectives The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies. Methods Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland). Results The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR. Conclusions Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/myc.13250</identifier><identifier>PMID: 33529398</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Candida ; Candida auris ; colonisation ; Hospitals ; Laboratories ; Mass spectroscopy ; Polymerase chain reaction ; Surveillance ; Transport media ; yeasts</subject><ispartof>Mycoses, 2021-06, Vol.64 (6), p.612-615</ispartof><rights>2021 Wiley‐VCH GmbH</rights><rights>2021 Wiley-VCH GmbH.</rights><rights>2021 Blackwell Verlag GmbH</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</citedby><cites>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</cites><orcidid>0000-0003-0678-9068</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33529398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulet Bayona, Juan V.</creatorcontrib><creatorcontrib>Salvador García, Carme</creatorcontrib><creatorcontrib>Tormo Palop, Nuria</creatorcontrib><creatorcontrib>Gimeno Cardona, Concepción</creatorcontrib><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><title>Mycoses</title><addtitle>Mycoses</addtitle><description>Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step. Objectives The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies. Methods Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland). Results The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR. Conclusions Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</description><subject>Candida</subject><subject>Candida auris</subject><subject>colonisation</subject><subject>Hospitals</subject><subject>Laboratories</subject><subject>Mass spectroscopy</subject><subject>Polymerase chain reaction</subject><subject>Surveillance</subject><subject>Transport media</subject><subject>yeasts</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kctq3TAQhkVpaU6TLPICQdBNsnCii2XLy2JyKaS0lCSQlZDlEShY1qlkN5xdoC_QZ-yTVKc-6aJQbQbEN98M8yN0RMkZze_cb8wZ5UyQV2hFS94URJD6NVqRhvOiLkm9h96l9EgIrRtWvUV7nAvW8Eau0I97PbheTy6MWI89dn49gIdxWr6CxRqb4D1E4_SAI-jh1_PPyXnAX9qvWKekN9iGiHsXwUy4hymXXWubjVmO9RxdwjYGj9Mcv4MbBj0awElvp6UD9MbqIcHhru6ju8uL2_a6uPl89bH9cFMYLjgpmC07LhrT9bKSgpHOagnQNZaCphXtoKsNl4ySqjY90VyAZKIUwGzV1HVP-D46WbzrGL7NkCblXTKwXQbCnBQrZUVLIaXI6Pt_0McwxzFvp5hgJck3pSxTpwtlYkgpglXr6LyOG0WJ2iajcjLqTzKZPd4Z585D_5d8iSID5wvw5AbY_N-kPj20i_I3yx2Zww</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Mulet Bayona, Juan V.</creator><creator>Salvador García, Carme</creator><creator>Tormo Palop, Nuria</creator><creator>Gimeno Cardona, Concepción</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0678-9068</orcidid></search><sort><creationdate>202106</creationdate><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><author>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Candida</topic><topic>Candida auris</topic><topic>colonisation</topic><topic>Hospitals</topic><topic>Laboratories</topic><topic>Mass spectroscopy</topic><topic>Polymerase chain reaction</topic><topic>Surveillance</topic><topic>Transport media</topic><topic>yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulet Bayona, Juan V.</creatorcontrib><creatorcontrib>Salvador García, Carme</creatorcontrib><creatorcontrib>Tormo Palop, Nuria</creatorcontrib><creatorcontrib>Gimeno Cardona, Concepción</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulet Bayona, Juan V.</au><au>Salvador García, Carme</au><au>Tormo Palop, Nuria</au><au>Gimeno Cardona, Concepción</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</atitle><jtitle>Mycoses</jtitle><addtitle>Mycoses</addtitle><date>2021-06</date><risdate>2021</risdate><volume>64</volume><issue>6</issue><spage>612</spage><epage>615</epage><pages>612-615</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step. Objectives The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies. Methods Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland). Results The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR. Conclusions Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33529398</pmid><doi>10.1111/myc.13250</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0678-9068</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0933-7407
ispartof Mycoses, 2021-06, Vol.64 (6), p.612-615
issn 0933-7407
1439-0507
language eng
recordid cdi_proquest_miscellaneous_2486145885
source Wiley-Blackwell Read & Publish Collection
subjects Candida
Candida auris
colonisation
Hospitals
Laboratories
Mass spectroscopy
Polymerase chain reaction
Surveillance
Transport media
yeasts
title Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20and%20implementation%20of%20a%20commercial%20real%E2%80%90time%20PCR%20assay%20for%20direct%20detection%20of%20Candida%20auris%20from%20surveillance%20samples&rft.jtitle=Mycoses&rft.au=Mulet%20Bayona,%20Juan%20V.&rft.date=2021-06&rft.volume=64&rft.issue=6&rft.spage=612&rft.epage=615&rft.pages=612-615&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/myc.13250&rft_dat=%3Cproquest_cross%3E2486145885%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2524040712&rft_id=info:pmid/33529398&rfr_iscdi=true